If this email is not displaying properly or to share with a colleague, please {View as Webpage}
| |
|
New Jersey Primary Care Practice
a Model for Treating Patients with OUD
| |
|
Jefferson Health, a primary care practice in Marlton, New Jersey, is rethinking how they treat their patients with opioid use disorders (OUD) thanks to the Providers Clinical Support System (PCSS) Implementation project.
PCSS Implementation provides training and mentorship in creating systems and implementation guidance, as well as educational resources and support at no cost to healthcare professionals and organizations in evidence-based practices in the prevention and treatment of substance use disorders, particularly opioid use disorder.
In 2020, the practice began participating in the PCSS Implementation project and quickly learned that treating OUD is more about harm reduction than following rigid policies, says Andrew Johnstone, APN, FNP, MSN, BC, who spearheaded the clinic’s transition to treating more of their patients with medications for OUD (MOUD). [Read more]
| |
Save the Dates: New PCSS Exchange Begins Soon! | |
|
PCSS-Exhange is a six-session course, live via Zoom webinar, focused on implementing prescribing medications for treating opioid use disorder in a variety of healthcare settings.
PCSS-X is intended for an interprofessional audience, and participants are welcome to attend whichever sessions are most relevant to their current situation. Prescribers with frontline experience prescribing medications for opioid use disorder and developing clinic workflows will be available during each session to answer participants’ questions and discuss real-world cases.
Sessions are held every other Wednesday starting May 18, 2022, at 3pm ET.
Dates are as follows:
May 18, June 1, June 15, June 29, July 13,July 27
Registration coming soon!
| |
All PCSS webinars are recorded and are available for on demand viewing, usually within two weeks of live webinar (and often sooner). Recent webinars that are now available: | |
PCSS Clinical Roundtables | |
|
Feedback Requested on Racial Equity Initiative Action Plan
The National Institute on Drug Abuse (NIDA) is inviting feedback on its draft NIDA Racial Equity Initiative Action Plan. NIDA is developing its Racial Equity Initiative to organize and refocus the Institute’s efforts around the goal of addressing the impact of structural racism on addiction science and to take action to promote racial equity in NIDA’s workplace, workforce, and research portfolio.
For additional information, including a link to the action plan and instructions for submitting feedback, please visit: https://grants.nih.gov/grants/guide/notice-files/NOT-DA-22-052.html
To ensure full consideration, responses must be received by April 30, 2022.
| |
|
National Suicide Prevention Lifeline
In July 2022, a National Suicide Prevention Lifeline will make crisis services more accessible with the adoption of 988 as the easy to remember three-digit dialing, texting, and chat code for anyone experiencing a suicidal or mental health related crisis. As the U.S-based universal dialing code connecting to the existing National Suicide Prevention Lifeline (Lifeline)—a network of local crisis centers throughout the country—988 will increase the accessibility and use of life-saving interventions and resources.
https://suicidepreventionmessaging.org/988messaging/framework
| |
|
Drug Use Severity in Adolescence Affects SUD Risk in Adulthood
People who reported multiple symptoms consistent with severe substance use disorder at age 18 exhibited two or more of these symptoms in adulthood, according to a new analysis of a nationwide survey in the United States. These individuals were also more likely, as adults, to use and misuse prescription medications, as well as self-treat with opioids, sedatives, or tranquillizers. Published today in JAMA Network Open, the study is funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.
[Read more]
| |
|
NIDA Competition Seeking Products to Help with Drug Cravings
The National Institute on Drug Abuse (NIDA) recently launched the “Product Prototypes to Combat Drug Craving” Challenge competition to solicit working prototypes of multifaceted products that will help with drug craving for those who experience substance use problems or those with substance use disorder (SUD). The Challenge will offer up to $50,000 for first place and up to $35,000 for second place entries, as well as up to three honorable mention awards of up to $5,000 each. Submissions are due August 31, 2022.
Submission Due Date: August 31, 2022, 6:00 p.m. ET
Judging Period: September 12, 2022 to September 30, 2022
Winners Announced: October 7, 2022
The submission package includes a 5-page written narrative describing the development of the product prototype and a brief 5-min video to showcase the working prototype and all its functions.
Learn more about the challenge, rules, and submission requirements here: https://www.challenge.gov/?challenge=product-prototypes-to-combat-drug-craving-challenge.
| |
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
| | | | | |
